BLUEPRINT MEDICINES
Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the growing understanding of the molecular blueprint of cancer. Using its powerful Insights-to-Validation Platform and proprietary chemical library, Blueprint Medicines is working to develop new therapeutic compounds and combination therapies that target the molecular aberrations that cause cancer and the emerging resistance mechanisms that make it increasingly difficult to treat. Fou... nded in 2011 by a proven team of scientists and entrepreneurs with world-renowned expertise in the development of targeted cancer therapies, cancer genomics, and rational drug development, Blueprint Medicines is poised to realize the promise of the cancer data revolution: truly personalized therapies that improve outcomes and shift cancer to a manageable condition.
BLUEPRINT MEDICINES
Industry:
Bioinformatics Biotechnology Health Care Medical
Founded:
2011-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.blueprintmedicines.com
Total Employee:
251+
Status:
Active
Contact:
617-374-7580
Email Addresses:
[email protected]
Total Funding:
1.12 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Auris Health
Auris Health engages in the development of robotics technology for medical applications.
BodyCap
BodyCap specializes in the development of miniature electronic sensors &monitors for continual measurement.
Brassica Protection Products
An innovator in the research and development of nutritional ingredients derived from cruciferous vegetables.
CerRx
CerRx engages in the discovery and development of anticancer drugs such as Fenretinide and Safingol.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Effector Therapeutics
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Elite Surgical Affiliates
Elite Surgical Affiliates provides a complete spectrum of development and management services for surgery center operations.
Expansion Technologies
Expansion Technologies pioneers the use of the expansion microscopy bioimaging tool for biology, medicine, and beyond.
GORYO Chemical
GORYO Chemical is the only manufacturer specializing in fluorescent dyes in Japan.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Koliber Biosciences
Koliber Biosciences provides data science services including the development of predictive models for customers.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Phoenix Biotechnology
Phoenix Biotechnology engages in the research and development of therapeutic agents and treatment regimens for cancer.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
ShouTi
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR.
Theraclion
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound.
Cogent Biosciences
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
WUHAN YOUNGSEN BIOTECH CO., LTD
WUHAN YOUNGSEN BIOTECH CO., LTD specializes in the research and development, production, and sales of high-end medical devices.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-11-29 | Lengo Therapeutics | Lengo Therapeutics acquired by Blueprint Medicines | 250 M USD |
Investors List
Redmile Group
Redmile Group investment in Series C - Blueprint Medicines
Cowen Group
Cowen Group investment in Series C - Blueprint Medicines
Partner Fund Management
Partner Fund Management investment in Series C - Blueprint Medicines
Tavistock Life Sciences
Tavistock Life Sciences investment in Series C - Blueprint Medicines
Fidelity Biosciences
Fidelity Biosciences investment in Series C - Blueprint Medicines
Perceptive Advisors
Perceptive Advisors investment in Series C - Blueprint Medicines
Nextech Invest
Nextech Invest investment in Series C - Blueprint Medicines
Casdin Capital
Casdin Capital investment in Series C - Blueprint Medicines
RA Capital Management
RA Capital Management investment in Series C - Blueprint Medicines
Third Rock Ventures
Third Rock Ventures investment in Series C - Blueprint Medicines
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-20 | Blueprint Medicines Elevates Two Talented Leaders to its Executive Team |
| 2021-05-17 | Blueprint adds another BMS vet to its roster with new CSO |
Official Site Inspections
http://www.blueprintmedicines.com Semrush global rank: 1.92 M Semrush visits lastest month: 11.36 K
- Host name: 23.185.0.1
- IP address: 23.185.0.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Blueprint Medicines"
Blueprint Medicines
Targeting root causes of disease. We have a proven track record of developing medicines, and we aim to scale our impact by advancing innovative therapies for large patient populations with …See details»
Overview | Blueprint Medicines Corp.
Feb 13, 2025 [email protected]. Overview Recent news Mar 31, 2025 Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference. Feb 28, 2025 …See details»
Medical professionals - Blueprint Medicines
A team within Blueprint Medicines' global Medical Affairs organization is collaborating with research partners to use ‘real-world’ evidence from numerous sources to help providers more …See details»
Blueprint Medicines - LinkedIn
Blueprint Medicines | 59,751 followers on LinkedIn. Striving to improve and extend patients' lives | Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life ...See details»
Blueprint Medicines - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 617-374-7580 Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the …See details»
Blueprint Medicines (Italy) S.r.l.
[email protected]. Per richiedere informazioni mediche, per segnalare un evento collaterale o inoltrare un reclamo sul prodotto a Blueprint Medicines: …See details»
Blueprint Medicines - Craft
Blueprint Medicines has 5 employees across 4 locations and $508.82 m in annual revenue in FY 2024. See insights on Blueprint Medicines including office locations, competitors, revenue, …See details»
Blueprint Medicines Corp - Company Profile - GlobalData
Website www.blueprintmedicines.com Telephone 1 617 3747580. No of Employees 649. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange BPMC (NASD) Revenue (2024) …See details»
Search Medical Information | Blueprint Medicines | HCP Site
To report an adverse reaction or product complaint, call 1-888-BLUPRNT, option 2, or visit or contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.See details»
Our mission and values - Blueprint Medicines
2022. We announced plans to expand our scientific platform to include targeted protein degradation, a therapeutic modality that complements and leverages our capability and …See details»
Blueprint Medicines - Overview, News & Similar companies
Blueprint Medicines contact info: Phone number: (617) 374-7580 Website: www.blueprintmedicines.com What does Blueprint Medicines do? Blueprint Medicines was …See details»
Blueprint Medicines (Switzerland GmbH) – Swiss Biotech
Blueprint Medicines is a global precision therapy company inventing life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, …See details»
Blueprint Medicines (LON:0HOJ) Company Profile & Description
Mar 28, 2025 Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and …See details»
Blueprint Medicines Provides 2025 Outlook and Highlights …
Jan 12, 2025 Media Contact: Andrew Law, +1 (617) 844-8205, [email protected] Investor Contact: Cassie Saitow, +1 (617) 909-3127, [email protected]. Investor …See details»
Blueprint Medicines Announces "2020 Blueprint" Global Business …
CAMBRIDGE, Mass., Jan. 4, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases …See details»
Our responsibility - Blueprint Medicines
We support: Tools and resources to help employees prioritize health, financial and overall wellbeing, including a Work Well Program focused on finding harmony between work and life, …See details»
Blueprint Medicines Publishes Inaugural Corporate Responsibility …
Jul 14, 2022 Media Contact: Sarah Mena Guerrero, [email protected], +1 (617) 714-6684; Investor Contact: Jim Baker, [email protected], +1 (617) 844-8236. …See details»
Our Blueprint | Blueprint Medicines
An interview with Amy Monpara and Rahul Kalathiya, Senior Medical Science Liaisons Across our organization, teams work together in pursuit of a common goal to… Read more Our dedication …See details»
Blueprint Medicines Forecasts Growth in SM and Inflammatory …
Jan 16, 2025 Blueprint Medicines Corporation projected continued growth in 2025 in their successful systemic mastocytosis (SM) drug development program, which is anchored by …See details»
Blueprint Medicines Highlights Leading Portfolio of Mast Cell …
Feb 28, 2025 "We are incredibly proud to showcase our mast cell therapy portfolio at AAAAI / WAO, with 14 presentations highlighting more than a decade of leadership and collaboration …See details»